- TLIS Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
-
Institutional
- Shorts
Talis Biomedical (TLIS) Institutional ownership
Company Profile
Type | Filer | #Shares | Filed | For date | #Previous | %Chg | Prev. Date |
---|---|---|---|---|---|---|---|
13F-HR
|
Steward Partners Investment Advisory | 147.00 | 14 Nov 24 | 30 Sep 24 | 147.00 | 0% | 30 Jun 24 |
13F-HR
|
BML Capital Management | 248.70 k | 5 Nov 24 | 30 Sep 24 | 42.74 k | +482% | 30 Jun 24 |
13F-HR/A
|
Morgan Stanley | 87.00 | 17 Oct 24 | 30 Jun 24 | 635.00 | -86% | 31 Mar 24 |
13F-HR/A
|
Morgan Stanley | 635.00 | 17 Oct 24 | 31 Mar 24 | 371.00 | +71% | 31 Dec 23 |
SC 13D/A
|
Baker Bros. Advisors | 2.51 mm | 10 Oct 24 | 8 Oct 24 | 508.32 k | +393% | 30 Jun 24 |
13F-HR
|
Proequities | 0.00 | 10 Oct 24 | 30 Sep 24 | 0.00 | 30 Jun 24 |
This data is updated daily from 13F, 13D and 13G SEC filings.
Faded values represent incomplete data for the quarter, where values have been used from the previous quarter for institutions that haven't filed updated data yet.
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.